Mesenchymal Stromal Cells Mitigate Experimental Colitis via Insulin-like Growth Factor Binding Protein 7-mediated Immunosuppression

Mesenchymal stromal cells (MSCs) have shown great potential for treating inflammatory bowel disease, which is ameliorated through paracrine cross talk between MSCs and T-cells. Members of the insulin-like growth factor binding protein (IGFBP) family have important immunomodulatory functions in MSCs,...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Mol Ther
Main Authors: Liao, Yan, Lei, Junxia, Liu, Muyun, Lin, Wanwen, Hong, Dongxi, Tuo, Ying, Jiang, Mei Hua, Xia, Huimin, Wang, Maosheng, Huang, Weijun, Xiang, Andy Peng
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2016
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5112041/
https://ncbi.nlm.nih.gov/pubmed/27397633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2016.140
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares